Position in DHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$231,433
+$1,069 QoQ
Shares Held
1,215
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.79%
of 13F equity value
Holder Rank
#1,699
of 2,098 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CADEN CAPITAL PARTNERS, LP holds $292,564 across 2 Diagnostics & Research names. DHR ranks #1 (79.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
1,215 | $231,433 | |
| 2 | WAT |
Waters Corp /De/
|
163 | $61,131 |
All Filings in DHR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,433 | 1,215 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $230,364 | 1,215 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $635,939 | 2,778 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,165,749 | 172,328 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,985,309 | 197,354 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,414,890 | 216,658 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $48,010,152 | 209,149 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $32,348,739 | 116,354 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,109,574 | 104,501 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $33,443,001 | 133,922 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,171,991 | 139,068 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $30,703,614 | 123,755 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $44,486,408 | 185,360 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $35,034,817 | 139,005 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $26,134,312 | 98,464 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||